Literature DB >> 20645915

Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.

G Luurtsema1, G L Verbeek, M Lubberink, A A Lammertsma, R Dierckx, P Elsinga, A D Windhorst, A van Waarde.   

Abstract

P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645915     DOI: 10.2174/156802610792928013

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  12 in total

1.  (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.

Authors:  Cristina Bolzati; Davide Carta; Valentina Gandin; Cristina Marzano; Nicolò Morellato; Nicola Salvarese; Mariangela Cantore; Nicola Antonio Colabufo
Journal:  J Biol Inorg Chem       Date:  2013-03-31       Impact factor: 3.358

2.  Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein.

Authors:  Debora Petroni; Antonietta Bartoli; Simona Rapposelli; Maria Digiacomo; Silvia Burchielli; Giulia Nesi; Annalina Lapucci; Silvia Pardini; Sabrina Fucci; Marco Macchia; Piero A Salvadori; Luca Menichetti
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 3.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

Review 4.  Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

Authors:  Stina Syvänen; Jonas Eriksson
Journal:  ACS Chem Neurosci       Date:  2012-12-04       Impact factor: 4.418

5.  Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113.

Authors:  Severin Mairinger; Thomas Wanek; Claudia Kuntner; Yaprak Doenmez; Sabine Strommer; Johann Stanek; Elena Capparelli; Peter Chiba; Markus Müller; Nicola A Colabufo; Oliver Langer
Journal:  Nucl Med Biol       Date:  2012-09-13       Impact factor: 2.408

6.  Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrier.

Authors:  Pavitra Kannan; Victor W Pike; Christer Halldin; Oliver Langer; Michael M Gottesman; Robert B Innis; Matthew D Hall
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

7.  [11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats.

Authors:  Joost Verbeek; Jonas Eriksson; Stina Syvänen; Maaike Labots; Elizabeth C M de Lange; Rob A Voskuyl; Martinus P J Mooijer; Marissa Rongen; Adriaan A Lammertsma; Albert D Windhorst
Journal:  EJNMMI Res       Date:  2012-07-02       Impact factor: 3.138

8.  The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.

Authors:  Gabriela Nestal de Moraes; Paloma Silva Souza; Fernanda Casal de Faria Costas; Flavia Cunha Vasconcelos; Flaviana Ruade Souza Reis; Raquel Ciuvalschi Maia
Journal:  Leuk Res Treatment       Date:  2012-04-24

9.  Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography.

Authors:  Julia Müllauer; Claudia Kuntner; Martin Bauer; Jens P Bankstahl; Markus Müller; Rob A Voskuyl; Oliver Langer; Stina Syvänen
Journal:  EJNMMI Res       Date:  2012-10-16       Impact factor: 3.138

Review 10.  Insight into the Molecular Imaging of Alzheimer's Disease.

Authors:  Abishek Arora; Neeta Bhagat
Journal:  Int J Biomed Imaging       Date:  2016-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.